{
  "fullName": "S. K. Sharma",
  "slug": "s-k-sharma",
  "title": "MD",
  "specialty": "Tuberculosis",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 114,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "S. K. Sharma was an Indian cricket umpire. He stood in ten ODI games from 1993 to 2002.",
  "aiSummary": "S. K. Sharma is a tuberculosis specialist with an H-index of 114 at AIIMS (Faculty). Has been published in New England Journal of Medicine, The Lancet, Nature Medicine. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "AIIMS Delhi"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "AIIMS",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Tuberculosis"
  ],
  "knowsAbout": [
    "National TB protocols"
  ],
  "citations": [
    {
      "title": "Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 6417,
      "doi": "10.1056/nejmoa1911303",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1911303",
      "verified": true
    },
    {
      "title": "Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction",
      "journal": "New England Journal of Medicine",
      "year": 2022,
      "citationCount": 2374,
      "doi": "10.1056/nejmoa2206286",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2206286",
      "verified": true
    },
    {
      "title": "Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association",
      "journal": "Circulation",
      "year": 2023,
      "citationCount": 1230,
      "doi": "10.1161/cir.0000000000001184",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000001184",
      "verified": true
    },
    {
      "title": "Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity",
      "journal": "New England Journal of Medicine",
      "year": 2023,
      "citationCount": 1197,
      "doi": "10.1056/nejmoa2306963",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2306963",
      "verified": true
    },
    {
      "title": "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease",
      "journal": "New England Journal of Medicine",
      "year": 2020,
      "citationCount": 1116,
      "doi": "10.1056/nejmoa2030186",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2030186",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline",
      "journal": "The Journal of Clinical Endocrinology & Metabolism",
      "year": 2012,
      "citationCount": 1112,
      "doi": "10.1210/jc.2011-2098",
      "sourceUrl": "https://doi.org/10.1210/jc.2011-2098",
      "verified": true
    },
    {
      "title": "Excess Mortality among Persons with Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2015,
      "citationCount": 965,
      "doi": "10.1056/nejmoa1504347",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1504347",
      "verified": true
    },
    {
      "title": "Glycemic Control and Excess Mortality in Type 1 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 910,
      "doi": "10.1056/nejmoa1408214",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1408214",
      "verified": true
    },
    {
      "title": "Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials",
      "journal": "Diabetes Care",
      "year": 2008,
      "citationCount": 881,
      "doi": "10.2337/dc08-9026",
      "sourceUrl": "https://doi.org/10.2337/dc08-9026",
      "verified": true
    },
    {
      "title": "SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials",
      "journal": "The Lancet",
      "year": 2022,
      "citationCount": 817,
      "doi": "10.1016/s0140-6736(22)01429-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(22)01429-5",
      "verified": true
    },
    {
      "title": "A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association",
      "journal": "Circulation",
      "year": 2023,
      "citationCount": 814,
      "doi": "10.1161/cir.0000000000001186",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000001186",
      "verified": true
    },
    {
      "title": "The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial",
      "journal": "Nature Medicine",
      "year": 2022,
      "citationCount": 807,
      "doi": "10.1038/s41591-021-01659-1",
      "sourceUrl": "https://doi.org/10.1038/s41591-021-01659-1",
      "verified": true
    },
    {
      "title": "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs",
      "journal": "Circulation",
      "year": 2017,
      "citationCount": 791,
      "doi": "10.1161/circulationaha.117.029190",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.117.029190",
      "verified": true
    },
    {
      "title": "The Obesity Paradox",
      "journal": "Archives of Internal Medicine",
      "year": 2005,
      "citationCount": 790,
      "doi": "10.1001/archinte.165.1.55",
      "sourceUrl": "https://doi.org/10.1001/archinte.165.1.55",
      "verified": true
    },
    {
      "title": "Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction",
      "journal": "Circulation",
      "year": 2005,
      "citationCount": 664,
      "doi": "10.1161/circulationaha.104.517839",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.104.517839",
      "verified": true
    },
    {
      "title": "Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update",
      "journal": "Circulation",
      "year": 2019,
      "citationCount": 586,
      "doi": "10.1161/cir.0000000000000691",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000000691",
      "verified": true
    },
    {
      "title": "Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions",
      "journal": "JACC: Cardiovascular Interventions",
      "year": 2014,
      "citationCount": 585,
      "doi": "10.1016/j.jcin.2013.06.016",
      "sourceUrl": "https://doi.org/10.1016/j.jcin.2013.06.016",
      "verified": true
    },
    {
      "title": "The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial",
      "journal": "Nature Medicine",
      "year": 2021,
      "citationCount": 570,
      "doi": "10.1038/s41591-021-01536-x",
      "sourceUrl": "https://doi.org/10.1038/s41591-021-01536-x",
      "verified": true
    },
    {
      "title": "Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction",
      "journal": "New England Journal of Medicine",
      "year": 2024,
      "citationCount": 519,
      "doi": "10.1056/nejmoa2407107",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2407107",
      "verified": true
    },
    {
      "title": "Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes",
      "journal": "JAMA",
      "year": 2020,
      "citationCount": 515,
      "doi": "10.1001/jama.2020.1906",
      "sourceUrl": "https://doi.org/10.1001/jama.2020.1906",
      "verified": true
    },
    {
      "title": "Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2024,
      "citationCount": 510,
      "doi": "10.1056/nejmoa2313917",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2313917",
      "verified": true
    },
    {
      "title": "Hyperglycemia and Acute Coronary Syndrome",
      "journal": "Circulation",
      "year": 2008,
      "citationCount": 489,
      "doi": "10.1161/circulationaha.107.188629",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.107.188629",
      "verified": true
    },
    {
      "title": "Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association",
      "journal": "Circulation",
      "year": 2016,
      "citationCount": 488,
      "doi": "10.1161/cir.0000000000000450",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000000450",
      "verified": true
    },
    {
      "title": "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association",
      "journal": "Diabetes Care",
      "year": 2015,
      "citationCount": 483,
      "doi": "10.2337/dci15-0012",
      "sourceUrl": "https://doi.org/10.2337/dci15-0012",
      "verified": true
    },
    {
      "title": "Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials",
      "journal": "Journal of the American College of Cardiology",
      "year": 2009,
      "citationCount": 468,
      "doi": "10.1016/j.jacc.2008.10.008",
      "sourceUrl": "https://doi.org/10.1016/j.jacc.2008.10.008",
      "verified": true
    },
    {
      "title": "Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs",
      "journal": "Journal of the American College of Cardiology",
      "year": 2018,
      "citationCount": 454,
      "doi": "10.1016/j.jacc.2018.03.009",
      "sourceUrl": "https://doi.org/10.1016/j.jacc.2018.03.009",
      "verified": true
    },
    {
      "title": "2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes",
      "journal": "Journal of the American College of Cardiology",
      "year": 2020,
      "citationCount": 452,
      "doi": "10.1016/j.jacc.2020.05.037",
      "sourceUrl": "https://doi.org/10.1016/j.jacc.2020.05.037",
      "verified": true
    },
    {
      "title": "10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i>",
      "journal": "Diabetes Care",
      "year": 2022,
      "citationCount": 449,
      "doi": "10.2337/dc23-s010",
      "sourceUrl": "https://doi.org/10.2337/dc23-s010",
      "verified": true
    },
    {
      "title": "American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update",
      "journal": "Endocrine Practice",
      "year": 2022,
      "citationCount": 430,
      "doi": "10.1016/j.eprac.2022.08.002",
      "sourceUrl": "https://doi.org/10.1016/j.eprac.2022.08.002",
      "verified": true
    },
    {
      "title": "Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction",
      "journal": "Circulation",
      "year": 2019,
      "citationCount": 415,
      "doi": "10.1161/circulationaha.119.042929",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.119.042929",
      "verified": true
    },
    {
      "title": "Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia",
      "journal": "JAMA",
      "year": 2014,
      "citationCount": 392,
      "doi": "10.1001/jama.2014.15688",
      "sourceUrl": "https://doi.org/10.1001/jama.2014.15688",
      "verified": true
    },
    {
      "title": "Glucometrics in Patients Hospitalized With Acute Myocardial Infarction",
      "journal": "Circulation",
      "year": 2008,
      "citationCount": 384,
      "doi": "10.1161/circulationaha.107.740498",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.107.740498",
      "verified": true
    },
    {
      "title": "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence",
      "journal": "Circulation",
      "year": 2015,
      "citationCount": 375,
      "doi": "10.1161/cir.0000000000000230",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000000230",
      "verified": true
    },
    {
      "title": "Serum Potassium Levels and Mortality in Acute Myocardial Infarction",
      "journal": "JAMA",
      "year": 2012,
      "citationCount": 370,
      "doi": "10.1001/jama.2011.1967",
      "sourceUrl": "https://doi.org/10.1001/jama.2011.1967",
      "verified": true
    },
    {
      "title": "Renoprotective effects of sodium-glucose cotransporter-2 inhibitors",
      "journal": "Kidney International",
      "year": 2018,
      "citationCount": 369,
      "doi": "10.1016/j.kint.2017.12.027",
      "sourceUrl": "https://doi.org/10.1016/j.kint.2017.12.027",
      "verified": true
    },
    {
      "title": "Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction",
      "journal": "JAMA",
      "year": 2009,
      "citationCount": 368,
      "doi": "10.1001/jama.2009.496",
      "sourceUrl": "https://doi.org/10.1001/jama.2009.496",
      "verified": true
    },
    {
      "title": "10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2024</i>",
      "journal": "Diabetes Care",
      "year": 2023,
      "citationCount": 364,
      "doi": "10.2337/dc24-s010",
      "sourceUrl": "https://doi.org/10.2337/dc24-s010",
      "verified": true
    },
    {
      "title": "Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials",
      "journal": "Circulation",
      "year": 2008,
      "citationCount": 345,
      "doi": "10.1161/circulationaha.108.191305",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.108.191305",
      "verified": true
    },
    {
      "title": "Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction",
      "journal": "Circulation",
      "year": 2019,
      "citationCount": 335,
      "doi": "10.1161/circulationaha.119.044138",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.119.044138",
      "verified": true
    },
    {
      "title": "Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the <scp>DELIVER</scp> trial",
      "journal": "European Journal of Heart Failure",
      "year": 2021,
      "citationCount": 306,
      "doi": "10.1002/ejhf.2249",
      "sourceUrl": "https://doi.org/10.1002/ejhf.2249",
      "verified": true
    },
    {
      "title": "2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease",
      "journal": "Journal of the American College of Cardiology",
      "year": 2018,
      "citationCount": 305,
      "doi": "10.1016/j.jacc.2018.09.020",
      "sourceUrl": "https://doi.org/10.1016/j.jacc.2018.09.020",
      "verified": true
    },
    {
      "title": "Introduction and Methodology: <i>Standards of Care in Diabetes—2023</i>",
      "journal": "Diabetes Care",
      "year": 2022,
      "citationCount": 299,
      "doi": "10.2337/dc23-sint",
      "sourceUrl": "https://doi.org/10.2337/dc23-sint",
      "verified": true
    },
    {
      "title": "Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study",
      "journal": "The Lancet Diabetes & Endocrinology",
      "year": 2019,
      "citationCount": 295,
      "doi": "10.1016/s2213-8587(19)30384-5",
      "sourceUrl": "https://doi.org/10.1016/s2213-8587(19)30384-5",
      "verified": true
    },
    {
      "title": "Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure?",
      "journal": "Journal of Cardiac Failure",
      "year": 2003,
      "citationCount": 289,
      "doi": "10.1054/jcaf.2003.3",
      "sourceUrl": "https://doi.org/10.1054/jcaf.2003.3",
      "verified": true
    },
    {
      "title": "Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction",
      "journal": "Circulation",
      "year": 2020,
      "citationCount": 287,
      "doi": "10.1161/circulationaha.120.050391",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.120.050391",
      "verified": true
    },
    {
      "title": "The prognostic importance of anemia in patients with heart failure",
      "journal": "The American Journal of Medicine",
      "year": 2003,
      "citationCount": 283,
      "doi": "10.1016/s0002-9343(02)01498-5",
      "sourceUrl": "https://doi.org/10.1016/s0002-9343(02)01498-5",
      "verified": true
    },
    {
      "title": "Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association",
      "journal": "Circulation",
      "year": 2020,
      "citationCount": 280,
      "doi": "10.1161/cir.0000000000000766",
      "sourceUrl": "https://doi.org/10.1161/cir.0000000000000766",
      "verified": true
    },
    {
      "title": "Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?",
      "journal": "Journal of the American College of Cardiology",
      "year": 2002,
      "citationCount": 277,
      "doi": "10.1016/s0735-1097(02)82070-8",
      "sourceUrl": "https://doi.org/10.1016/s0735-1097(02)82070-8",
      "verified": true
    },
    {
      "title": "Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials",
      "journal": "The Lancet",
      "year": 2024,
      "citationCount": 269,
      "doi": "10.1016/s0140-6736(24)00469-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(24)00469-0",
      "verified": true
    },
    {
      "title": "Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure",
      "journal": "Circulation",
      "year": 2021,
      "citationCount": 260,
      "doi": "10.1161/circulationaha.120.052503",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.120.052503",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:19.000Z",
  "openalexId": "https://openalex.org/A5052533254"
}